Share
Explore BrainMass

A discusssion on Phatmaceutical Test Groups

Assume that you work for the Food and Drug Administration. A pharmaceutical company has applied for approval to market a new arthritis medication. The research involved a test group that was given the medication and another test group that was given a placebo.

Respond to the following:
• Describe some ways in which the test groups might not be representative of the population of people with arthritis.
• If the company itself paid for or conducted its own research, would you have any concerns? Why or why not?
• If the study was not conducted as a blind or a double-blind test would you have any concerns? Why or why not?

Solution Preview

• Describe some ways in which the test groups might not be representative of the population of people with arthritis.
One way is that all people in the test groups are over 60 years old. So the test groups are not representative of the population of people with arthritis under 60 years old.
Another ways is that the researchers pick up the people in the test groups from one region only. So the test groups are not ...

Solution Summary

The solution gives detailed discusssion on Phatmaceutical Test Groups. Further, a study on a blind or a double-blind test is also incooperated.

$2.19